Hematopoietic stem cells: Are they CD34-positive or CD34-negative?
- dualism. // Taber's Cyclopedic Medical Dictionary (2009);2009, Issue 21, p697
Definitions of the term "dualism," which could pertain to the theory that various blood cells come from two types of stem cells, are presented.
- Blood brothers. Richardson, Sarah // Discover;Jan2000, Vol. 21 Issue 1, p63
Reports on research where neural stem cells were transformed into blood cells in mice.
- monophyletism. // Taber's Cyclopedic Medical Dictionary (2009);2009, Issue 21, p1489
A definition of the term "monophyletism," which refers to the hypothesis that all blood cells came from a single stem cell, is presented.
- A clonogenic common myeloid progenitor that give rise to all myeloid lineages. Akashi, Koichi; Traver, David // Nature;3/9/2000, Vol. 404 Issue 6774, p193
Identifies a clonogenic common lymphoid progenitor from hematopoietic stem cells that can differentiate into T, B and natural killer cells but not myeloid cells. Use of cell-surface markers and flow cytometry to identify a common myeloid progenitor; Expression profile of hematopoiesis-related...
- Reprogrammed Blood Cells in Research. // BioWorld Today;7/12/2010, Vol. 21 Issue 132, Special section p1
The article discusses research study on the reprogramming of cells from frozen human blood samples to an embryonic-stem-cell-like state, published in the July 2, 2010 issue of the journal "Cell Stem Cell."
- New technology gets stem cells from blood cells. // Machine Design;4/17/2003, Vol. 75 Issue 8, p30
Reports on a technology from researchers at Argonne National Laboratory that modifies adult blood cells into pluripotent stem cells. Details on how researchers created the cells.
- Immunobiology of allogeneic peripheral blood mononuclear cells mobilized with granulocyte-colony stimulating factor. Gyger, M; Stuart, R K; Perreault, C // Bone Marrow Transplantation;7/1/2000, Vol. 26 Issue 1, p1
The use of mobilized peripheral blood (PB) stem cells for autologous transplantation initially generated much enthusiasm because of enhanced engraftment in comparison to marrow stem cells and avoidance of general anesthesia for the donor. Its application to the allogeneic setting seemed...
- When and How to Treat Essential Thrombocythemia. Barbui, Tiziano; Finazzi, Guido // New England Journal of Medicine;7/7/2005, Vol. 353 Issue 1, p85
Comments on how to treat essential thrombocythemia, which involves clonal hematopoietic stem cells. Details of risk factors for thrombotic events in patients with essential thrombocythemia including age; Use of hydroxyurea as a treatment for thrombocythemia; Details of a study conducted by...
- Donor cell type can influence the epigenome and differentiation potential of human induced pluripotent stem cells. Kim, Kitai; Zhao, Rui; Doi, Akiko; Ng, Kitwa; Unternaehrer, Juli; Cahan, Patrick; Hongguang, Huo; Loh, Yuin-Han; Aryee, Martin J; Lensch, M William; Li, Hu; Collins, James J; Feinberg, Andrew P; Daley, George Q // Nature Biotechnology;Dec2011, Vol. 29 Issue 12, p1117
We compared bona fide human induced pluripotent stem cells (iPSCs) derived from umbilical cord blood (CB) cells and neonatal keratinocytes (K). As a consequence of both incomplete erasure of tissue-specific methylation and aberrant de novo methylation, CB-iPSCs and K-iPSCs were distinct in...